LAURUS LABS LIMITED |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 443.6 INR | -0.72% |
|
-2.78% | +3.14% |
| 05-15 | Granules India posts Q4 revenue fall on weak paracetamol sales, price erosion | RE |
| 04-25 | Transcript : Laurus Labs Limited, Q4 2024 Earnings Call, Apr 25, 2024 |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Other Pharmaceuticals
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 2.9B | ||||||
| 727B | ||||||
| 347B | ||||||
| 319B | ||||||
| 274B | ||||||
| 238B |
